SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-003916
Filing Date
2024-01-08
Accepted
2024-01-08 07:50:30
Documents
18
Period of Report
2024-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d110586d8k.htm   iXBRL 8-K 55619
2 EX-2.1 d110586dex21.htm EX-2.1 460277
3 EX-99.1 d110586dex991.htm EX-99.1 17862
4 EX-99.2 d110586dex992.htm EX-99.2 17711
5 EX-99.3 d110586dex993.htm EX-99.3 37038
6 EX-99.4 d110586dex994.htm EX-99.4 988
7 EX-99.5 d110586dex995.htm EX-99.5 13878
  Complete submission text file 0001193125-24-003916.txt   875825

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA amam-20240105.xsd EX-101.SCH 2843
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE amam-20240105_lab.xml EX-101.LAB 17977
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amam-20240105_pre.xml EX-101.PRE 11253
12 EXTRACTED XBRL INSTANCE DOCUMENT d110586d8k_htm.xml XML 3352
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Filer) CIK: 0001990550 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56600 | Film No.: 24518370
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)